|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investments (includes assets measured at fair value of $296,951 and $231,929 including assets sold under agreements to repurchase of $173,156 and $157,107 as of September 30, 2023 and December 31, 2022, respectively) | ||||||||||||||||||||
| Income and fees receivable | ||||||||||||||||||||
| Due from related parties | ||||||||||||||||||||
| Other Receivables | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Total Other Assets, Net | ||||||||||||||||||||
| Other assets of consolidated funds | ||||||||||||||||||||
| Assets of consolidated entities: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Investments of Consolidated Entities | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Compensation payable | ||||||||||||||||||||
| Unearned income and fees | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Tax receivable agreement liability | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Debt obligations | ||||||||||||||||||||
| Warrant liabilities, at fair value | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Other liabilities of consolidated funds | ||||||||||||||||||||
| Liabilities of consolidated entities: | ||||||||||||||||||||
| Notes payable, at fair value | ||||||||||||||||||||
| Warrant liabilities, at fair value | ||||||||||||||||||||
| Other liabilities of consolidated entities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests of consolidated entities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Common stock value | ||||||||||||||||||||
| Class A Shares | ||||||||||||||||||||
| Class B Shares | ||||||||||||||||||||
| Treasury Stock, Value | ||||||||||||||||||||
| Treasury stock, at cost; 3,022,380 as of September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Shareholders’ deficit attributable to Class A Shareholders | ||||||||||||||||||||
| Shareholders’ equity attributable to noncontrolling interests | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Common stock, par value per share | ||||||||||||||||||||
Loading...
